Episil-Precision Inc. Logo

Episil-Precision Inc.

3016.TW

(2.0)
Stock Price

59,30 TWD

2.96% ROA

3.4% ROE

81.16x PER

Market Cap.

16.792.969.800,00 TWD

25% DER

3.44% Yield

3.87% NPM

Episil-Precision Inc. Stock Analysis

Episil-Precision Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Episil-Precision Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (23%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

3 ROE

The stock's ROE falls within an average range (7.27%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (4.98%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Dividend Growth

With a history of consistent dividend increases over the last three years, the company has proven to be a reliable choice for investors seeking reliable income.

6 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (4.125) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's elevated P/BV ratio (3.71x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

10 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

11 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

Episil-Precision Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Episil-Precision Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Episil-Precision Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Episil-Precision Inc. Revenue
Year Revenue Growth
2009 477.350.000
2010 912.186.000 47.67%
2011 825.820.000 -10.46%
2012 748.276.000 -10.36%
2013 823.454.000 9.13%
2014 881.528.000 6.59%
2015 779.272.000 -13.12%
2016 2.790.990.000 72.08%
2017 3.342.938.000 16.51%
2018 4.524.026.000 26.11%
2019 3.854.729.000 -17.36%
2020 4.039.180.000 4.57%
2021 5.043.332.000 19.91%
2022 5.899.587.000 14.51%
2023 4.137.548.000 -42.59%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Episil-Precision Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2009 28.335.000
2010 24.281.000 -16.7%
2011 16.086.000 -50.94%
2012 19.615.000 17.99%
2013 15.504.000 -26.52%
2014 16.376.000 5.32%
2015 14.498.000 -12.95%
2016 54.071.000 73.19%
2017 76.615.000 29.43%
2018 77.708.000 1.41%
2019 61.660.000 -26.03%
2020 61.344.000 -0.52%
2021 68.520.000 10.47%
2022 70.091.000 2.24%
2023 81.380.000 13.87%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Episil-Precision Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 49.442.000
2010 61.150.000 19.15%
2011 61.591.000 0.72%
2012 58.705.000 -4.92%
2013 57.748.000 -1.66%
2014 59.246.000 2.53%
2015 67.512.000 12.24%
2016 115.654.000 41.63%
2017 110.173.000 -4.97%
2018 132.900.000 17.1%
2019 126.316.000 -5.21%
2020 124.798.000 -1.22%
2021 139.392.000 10.47%
2022 185.626.000 24.91%
2023 176.200.000 -5.35%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Episil-Precision Inc. EBITDA
Year EBITDA Growth
2009 42.862.000
2010 201.651.000 78.74%
2011 126.557.000 -59.34%
2012 70.630.000 -79.18%
2013 77.835.000 9.26%
2014 114.492.000 32.02%
2015 79.196.000 -44.57%
2016 280.988.000 71.82%
2017 411.015.000 31.64%
2018 836.039.000 50.84%
2019 439.246.000 -90.34%
2020 507.694.000 13.48%
2021 963.353.000 47.3%
2022 1.332.699.000 27.71%
2023 760.500.000 -75.24%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Episil-Precision Inc. Gross Profit
Year Gross Profit Growth
2009 -23.206.000
2010 161.724.000 114.35%
2011 106.929.000 -51.24%
2012 62.283.000 -71.68%
2013 84.754.000 26.51%
2014 94.462.000 10.28%
2015 50.170.000 -88.28%
2016 252.044.000 80.09%
2017 463.513.000 45.62%
2018 769.988.000 39.8%
2019 245.406.000 -213.76%
2020 243.959.000 -0.59%
2021 726.433.000 66.42%
2022 1.101.881.000 34.07%
2023 438.316.000 -151.39%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Episil-Precision Inc. Net Profit
Year Net Profit Growth
2009 -73.887.000
2010 76.317.000 196.82%
2011 14.001.000 -445.08%
2012 -48.074.000 129.12%
2013 -27.227.000 -76.57%
2014 16.602.000 264%
2015 -14.716.000 212.82%
2016 20.063.000 173.35%
2017 180.310.000 88.87%
2018 430.119.000 58.08%
2019 10.478.000 -4004.97%
2020 25.693.000 59.22%
2021 380.530.000 93.25%
2022 681.271.000 44.14%
2023 171.916.000 -296.28%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Episil-Precision Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 -1
2010 1 0%
2011 0 0%
2012 -1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 1 0%
2018 2 100%
2019 0 0%
2020 0 0%
2021 1 100%
2022 2 50%
2023 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Episil-Precision Inc. Free Cashflow
Year Free Cashflow Growth
2009 -190.488.000
2010 115.911.000 264.34%
2011 -161.542.000 171.75%
2012 72.009.000 324.34%
2013 131.375.000 45.19%
2014 78.293.000 -67.8%
2015 -61.207.000 227.92%
2016 332.677.000 118.4%
2017 -253.940.000 231.01%
2018 -558.430.000 54.53%
2019 35.405.000 1677.26%
2020 411.651.000 91.4%
2021 515.953.000 20.22%
2022 681.978.000 24.34%
2023 -36.208.000 1983.5%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Episil-Precision Inc. Operating Cashflow
Year Operating Cashflow Growth
2009 -439.000
2010 137.240.000 100.32%
2011 148.965.000 7.87%
2012 100.440.000 -48.31%
2013 152.594.000 34.18%
2014 155.479.000 1.86%
2015 -15.430.000 1107.64%
2016 542.181.000 102.85%
2017 168.674.000 -221.44%
2018 597.789.000 71.78%
2019 394.856.000 -51.39%
2020 496.231.000 20.43%
2021 692.462.000 28.34%
2022 1.160.382.000 40.32%
2023 112.682.000 -929.78%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Episil-Precision Inc. Capital Expenditure
Year Capital Expenditure Growth
2009 190.049.000
2010 21.329.000 -791.04%
2011 310.507.000 93.13%
2012 28.431.000 -992.14%
2013 21.219.000 -33.99%
2014 77.186.000 72.51%
2015 45.777.000 -68.61%
2016 209.504.000 78.15%
2017 422.614.000 50.43%
2018 1.156.219.000 63.45%
2019 359.451.000 -221.66%
2020 84.580.000 -324.98%
2021 176.509.000 52.08%
2022 478.404.000 63.1%
2023 148.890.000 -221.31%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Episil-Precision Inc. Equity
Year Equity Growth
2009 1.041.557.000
2010 1.121.614.000 7.14%
2011 1.089.845.000 -2.92%
2012 1.067.208.000 -2.12%
2013 1.037.572.000 -2.86%
2014 1.059.553.000 2.07%
2015 1.033.862.000 -2.48%
2016 2.700.319.000 61.71%
2017 3.517.485.000 23.23%
2018 4.056.187.000 13.28%
2019 3.819.702.000 -6.19%
2020 4.045.539.000 5.58%
2021 4.610.079.000 12.25%
2022 5.303.687.000 13.08%
2023 4.845.361.000 -9.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Episil-Precision Inc. Assets
Year Assets Growth
2009 1.283.631.000
2010 1.269.115.000 -1.14%
2011 1.468.301.000 13.57%
2012 1.460.764.000 -0.52%
2013 1.430.928.000 -2.09%
2014 1.203.538.000 -18.89%
2015 1.154.627.000 -4.24%
2016 3.492.423.000 66.94%
2017 4.801.150.000 27.26%
2018 6.009.763.000 20.11%
2019 6.022.219.000 0.21%
2020 5.965.564.000 -0.95%
2021 6.613.535.000 9.8%
2022 7.672.174.000 13.8%
2023 7.007.729.000 -9.48%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Episil-Precision Inc. Liabilities
Year Liabilities Growth
2009 242.074.000
2010 147.501.000 -64.12%
2011 378.456.000 61.03%
2012 393.556.000 3.84%
2013 393.356.000 -0.05%
2014 143.985.000 -173.19%
2015 120.765.000 -19.23%
2016 792.104.000 84.75%
2017 1.283.665.000 38.29%
2018 1.953.576.000 34.29%
2019 2.202.517.000 11.3%
2020 1.920.025.000 -14.71%
2021 2.003.456.000 4.16%
2022 2.368.487.000 15.41%
2023 2.162.368.000 -9.53%

Episil-Precision Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
15.91
Net Income per Share
0.72
Price to Earning Ratio
81.16x
Price To Sales Ratio
3.68x
POCF Ratio
20.26
PFCF Ratio
66.98
Price to Book Ratio
3.44
EV to Sales
3.42
EV Over EBITDA
19.81
EV to Operating CashFlow
18.92
EV to FreeCashFlow
62.1
Earnings Yield
0.01
FreeCashFlow Yield
0.01
Market Cap
16,79 Bil.
Enterprise Value
15,57 Bil.
Graham Number
16.52
Graham NetNet
5.67

Income Statement Metrics

Net Income per Share
0.72
Income Quality
3.16
ROE
0.04
Return On Assets
0.02
Return On Capital Employed
0.04
Net Income per EBT
0.8
EBT Per Ebit
0.86
Ebit per Revenue
0.06
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.12
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.04

Dividends

Dividend Yield
0.03
Dividend Yield %
3.44
Payout Ratio
0
Dividend Per Share
2

Operating Metrics

Operating Cashflow per Share
2.87
Free CashFlow per Share
0.88
Capex to Operating CashFlow
-0.7
Capex to Revenue
-0.13
Capex to Depreciation
-1.15
Return on Invested Capital
0.04
Return on Tangible Assets
0.03
Days Sales Outstanding
96.25
Days Payables Outstanding
31.96
Days of Inventory on Hand
81.77
Receivables Turnover
3.79
Payables Turnover
11.42
Inventory Turnover
4.46
Capex per Share
-2

Balance Sheet

Cash per Share
8,50
Book Value per Share
16,91
Tangible Book Value per Share
16.91
Shareholders Equity per Share
16.91
Interest Debt per Share
4.33
Debt to Equity
0.25
Debt to Assets
0.17
Net Debt to EBITDA
-1.55
Current Ratio
3.54
Tangible Asset Value
4,79 Bil.
Net Current Asset Value
2,38 Bil.
Invested Capital
0.25
Working Capital
3,26 Bil.
Intangibles to Total Assets
0.01
Average Receivables
1,17 Bil.
Average Payables
0,28 Bil.
Average Inventory
879464000
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Episil-Precision Inc. Dividends
Year Dividends Growth
2005 0
2006 0 0%
2007 1 0%
2008 1 0%
2011 0 0%
2012 0 0%
2015 0 0%
2018 1 0%
2019 1 100%
2020 0 0%
2021 0 0%
2022 1 100%
2023 2 50%

Episil-Precision Inc. Profile

About Episil-Precision Inc.

Episil-Precision Inc. engages in the research, development, production, and sale of epitaxial Si/SiC/GaN wafers in Taiwan and internationally. The company offers epitaxial wafers, such as silicon epitaxial, SiC on SiC epitaxial, and GaN-on-Si epitaxial wafers for use in power discretes, power ICs, image sensors, graded Epis, buried layer Epis, and multi-layer Epis. It also provides buried layer epitaxial services. The company was founded in 1998 and is headquartered in Hsinchu City, Taiwan. Episil-Precision Inc. is a subsidiary of Episil Holding Inc.

CEO
Mr. Ching-Tzong Sune
Employee
148
Address
No. 10 Dusing Road I
Hsinchu City, 30078

Episil-Precision Inc. Executives & BODs

Episil-Precision Inc. Executives & BODs
# Name Age
1 Mr. Ching-Tzong Sune
President & Representative Director
70

Episil-Precision Inc. Competitors